Using Magnetic Particle Imaging to improve brain tumor treatment
Magnetic Particle Imaging (MPI) for Imaging and Magnetothermal Therapy of Brain Tumors
This study is testing a new imaging method called Magnetic Particle Imaging to help doctors better see and treat brain tumors, especially glioblastoma, so that patients can have improved outcomes and safer options, particularly for those with kidney problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-10903792 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging technique called Magnetic Particle Imaging (MPI) to enhance the treatment of brain tumors, particularly glioblastoma multiforme. By utilizing MPI, the researchers aim to provide better imaging capabilities that can help guide therapies and improve outcomes for patients with brain cancer. The project combines expertise in nanomedicine and cancer biology to create a more effective approach to treating tumors that are often resistant to traditional therapies. The research will also explore the use of nanoparticle contrast agents that are safer for patients with kidney issues.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma multiforme or other types of brain tumors, especially those who are not responding well to current treatments.
Not a fit: Patients with brain tumors that are easily operable or those who do not have glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved imaging and treatment options for patients with brain tumors, potentially enhancing survival rates and quality of life.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for cancer treatment, suggesting that this approach could be a significant advancement in the field.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Arami, Hamed — Arizona State University-Tempe Campus
- Study coordinator: Arami, Hamed
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.